Sei Investments Co. Purchases 34,307 Shares of HealthEquity, Inc. (NASDAQ:HQY)

Sei Investments Co. raised its position in HealthEquity, Inc. (NASDAQ:HQY) by 5.4% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 664,676 shares of the company’s stock after buying an additional 34,307 shares during the quarter. Sei Investments Co. owned 0.77% of HealthEquity worth $63,776,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently modified their holdings of the company. Wealthfront Advisers LLC bought a new position in shares of HealthEquity in the fourth quarter worth $10,304,089,000. Wasatch Advisors LP raised its position in shares of HealthEquity by 6.6% in the 3rd quarter. Wasatch Advisors LP now owns 7,758,890 shares of the company’s stock valued at $635,065,000 after buying an additional 483,269 shares in the last quarter. Raymond James Financial Inc. acquired a new position in shares of HealthEquity in the 4th quarter valued at approximately $45,728,000. Geneva Capital Management LLC boosted its position in shares of HealthEquity by 24.6% during the 4th quarter. Geneva Capital Management LLC now owns 1,048,903 shares of the company’s stock worth $100,642,000 after acquiring an additional 206,894 shares in the last quarter. Finally, Barclays PLC increased its stake in HealthEquity by 209.3% in the third quarter. Barclays PLC now owns 166,492 shares of the company’s stock valued at $13,628,000 after acquiring an additional 112,667 shares during the last quarter. Institutional investors and hedge funds own 99.55% of the company’s stock.

Analyst Ratings Changes

A number of equities research analysts have weighed in on the company. Wells Fargo & Company raised their target price on HealthEquity from $110.00 to $125.00 and gave the company an “overweight” rating in a report on Wednesday, February 26th. Barrington Research reiterated an “outperform” rating and issued a $112.00 target price on shares of HealthEquity in a research report on Friday, March 14th. JMP Securities boosted their target price on HealthEquity from $105.00 to $107.00 and gave the stock a “market outperform” rating in a research note on Tuesday, December 10th. Raymond James lifted their price target on shares of HealthEquity from $105.00 to $120.00 and gave the company an “outperform” rating in a report on Tuesday, February 25th. Finally, Royal Bank of Canada increased their price objective on shares of HealthEquity from $100.00 to $105.00 and gave the company an “outperform” rating in a research note on Tuesday, December 10th. One research analyst has rated the stock with a hold rating and twelve have given a buy rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $112.92.

Insider Buying and Selling

In other news, Director Robert W. Selander sold 5,750 shares of HealthEquity stock in a transaction on Monday, February 10th. The shares were sold at an average price of $111.29, for a total value of $639,917.50. Following the completion of the sale, the director now owns 78,219 shares in the company, valued at $8,704,992.51. The trade was a 6.85 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. 2.20% of the stock is owned by insiders.

HealthEquity Stock Performance

NASDAQ:HQY opened at $84.88 on Monday. The company has a market capitalization of $7.36 billion, a PE ratio of 77.87, a P/E/G ratio of 1.60 and a beta of 0.62. HealthEquity, Inc. has a fifty-two week low of $65.01 and a fifty-two week high of $115.59. The company has a debt-to-equity ratio of 0.51, a quick ratio of 3.20 and a current ratio of 3.20. The company has a 50 day simple moving average of $104.90 and a two-hundred day simple moving average of $95.76.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.